Table of Contents

January/February 2025; Volume 79,Issue 1

  1. Haddad, Ghada

    1. 2025 January/February Editorial
      Ghada Haddad
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 1-3; DOI: https://doi.org/10.5731/pdajpst.2025.001941

  2. Harding, Alexa

    1. Visual Inspection of Topical Ophthalmic Formulations Packaged in Opaque and Semi-Transparent Containers: Working Towards Alignment with USP<790> Visible Particulates in Injections
      Mary Lee Ciolkowski, Ann T. Davis, Alexa Harding and Stacey M. Platzer
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 59-67; DOI: https://doi.org/10.5731/pdajpst.2024-003017.1

  3. Heise, Ted

    1. Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
      Dennis Jenke, Piet Christiaens and Ted Heise
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 98-113; DOI: https://doi.org/10.5731/pdajpst.2024.012945

  4. Hubmayr, David

    1. Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
      Mario Stassen, Catarina S. Leitão, Toni Manzano, Francisco Valero, Benjamin Stevens, Matt Schmucki, David Hubmayr, Ferran Mirabent Rubinat, Sandrine Dessoy and Antonio Moreira
      PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 68-87; DOI: https://doi.org/10.5731/pdajpst.2024.012950
Back to top

In This Issue